Linezolid versus vancomycin for prosthetic joint infections: A cost analysis
Publication in refereed journal


香港中文大学研究人员 ( 现职)

许明媚教授 (微生物学系)

姚凯诗教授 (药剂学院)

全文

数位物件识别号 (DOI) ○○@http://aims.cuhk.edu.hk/converis/portal/Publication/4$@○○

引用次数
Web of Sciencehttp://aims.cuhk.edu.hk/converis/portal/Publication/4WOS source URL

其它资讯

摘要Background: Prosthetic joint infections (PJIs) caused by methicillin-resistant gram-positive bacteria are primarily treated by intravenous vancomycin. Linezolid, active methicillin-resistant strains and available in oral and intravenous dosage forms, is a potential alternative to vancomycin for the treatment of PJIs.

着者You JHS, Lee GCH, So RKH, Cheung KW, Hui M
期刊名称Infection
详细描述2007.
出版年份2007
月份8
日期1
卷号35
期次http://aims.cuhk.edu.hk/converis/portal/Publication/4
出版社URBAN & VOGEL
页次265 - 270
国际标準期刊号0300-8126
电子国际标準期刊号1http://aims.cuhk.edu.hk/converis/portal/Publication/439-0973
语言英式英语

Web of Science 学科类别Infectious Diseases; INFECTIOUS DISEASES